Close menu




January 24th, 2020 | 14:11 CET

Beyond Meat, Burcon NutraScience, Nestle - scalable growth with plant proteins

  • Food
Photo credits: pixabay.com

Humanity is always striving for improvement. This has not only been the case since the climate debate, but innovations in all areas of everyday life are constantly changing our lives. The changes will never again be as slow as they are at this moment. Research and development solve problems or create new needs. In the ideal case even both. Nutritious and tasty food with an improved CO2 footprint is on the agenda of food producers like Beyond Meat and Nestle. But developing innovation costs not only money, but also time. The latter usually leads to partnerships or even takeovers.

time to read: 1 minutes | Author: Mario Hose
ISIN: CA1208311029 , US08862E1091 , CH0038863350

Table of contents:


    Pay for 20 years' work

    Burcon NutraScience from Canada has been working for 20 years on the development of plant proteins. As was announced today, the company has entered into a comprehensive partnership with one of the world's largest food companies.

    The partnership combines Nestle's expertise in the development, production and marketing of plant foods and beverages with Burcon's proprietary technology for the extraction and purification of plant proteins, while leveraging Burcon's JV partner Merit Food's state-of-the-art plant protein production facilities in Manitoba, Canada. The joint venture with production company Merit was only established in May 2019.

    Stefan Palzer, Nestle's Chief Technology Officer, explains the collaboration in the company's announcement: 'The partnership with Burcon and Merit will give us access to unique expertise and a new range of high-quality ingredients for plant-based food and beverages.'

    Meat substitute from the plant world

    The partnership with Nestle validates the expertise Burcon NutraScience has built over more than 20 years of research and development. The company now holds more than 270 patents relating to plant proteins, with a further 260 applications pending.

    Burcon NutraScience will be the first company in the world to combine canola and pea proteins. The mixed protein, called Nutratein, has the same amino acid profile as meat. The solubility of Burcon's proteins means that they can also be used in beverages and non-dairy products, another market with enormous potential.

    Beyond Meat gets competition

    In today's announcement, Nestle mentions that the company already has a vegetable product range consisting of pea, soya and wheat burgers, sausages, minced meat, chicken fillets and various other convenience foods. In addition, the company is also working on plant-based milk alternatives and milk-free ice creams.

    This new partnership between Burcon NutraScience and Nestle gives Beyond Meat a serious competitor. At the end of the day, the trend toward climate protection is moving in the right direction with increasing competition. For Burcon NutraScience the framework for scalable growth is now in place.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Mario Hose

    Born and raised in Hannover, Lower Saxony follows social and economic developments around the globe. As a passionate entrepreneur and columnist he explains and compares the most diverse business models as well as markets for interested stock traders.

    About the author



    Related comments:

    Commented by André Will-Laudien on July 1st, 2026 | 06:50 CEST

    Here We Go: A Breakthrough for Bayer, Buy Signals for MustGrow and Kraft Heinz

    • biologicals
    • Food
    • agritech
    • mustard
    • biofertilizer

    Created and Published on Behalf of MustGrow Biologics Corp.

    According to United Nations projections, the world's population is expected to grow to around 9.7 billion people by 2050. The Food and Agriculture Organization (FAO) estimates that this growth can only be managed with significantly more productive and, at the same time, more sustainable farming methods. This is where MustGrow Biologics comes in with biological crop solutions based on natural mustard extracts. And the company's growth story is only just beginning. The sector is gaining short-term momentum now that Bayer has finally received a positive ruling from the US Supreme Court regarding glyphosate. This should allow the Leverkusen-based company's Crop Science division to really take off. At the same time, a powerful structural trend is reshaping the entire agricultural value chain. Natural resources and food must be produced more sustainably and with greater resilience to meet the nutritional needs of a rapidly growing global population. Companies such as Kraft Heinz are responding by leveraging decades of expertise in building resilient agricultural supply chains and climate-adaptive farming systems. These are exciting developments in a sector that is often overlooked in the shadow of high-tech and defence. But the technological trends have long since shifted!

    Read

    Commented by Jens Castner on June 26th, 2026 | 07:30 CEST

    Idolized, Sold Off, Forgotten: What is Next for Coinbase, HelloFresh, and American Atomics

    • nuclear
    • Uranium
    • Energy
    • Food
    • crypto

    On the stock market today, more than ever, greed clouds judgment. When a trend persists long enough, the market begins to treat it as a law of nature—projecting growth rates into a future they are unlikely to sustain. Coinbase, HelloFresh, and American Atomics illustrate this dynamic in very different ways: from a leveraged crypto bet to a pandemic winner in decline to a uranium explorer that is arguably mispriced based on spot commodity sentiment. Now, far removed from their peak euphoria, all three are largely trading out of the spotlight. This raises a central question: which of these stocks deserves a second look?

    Read

    Commented by Carsten Mainitz on June 4th, 2026 | 07:45 CEST

    Takeover Fever! BioNxt Solutions, Delivery Hero, and Commerzbank in the Spotlight: How Investors Can Benefit!

    • Biotechnology
    • Biotech
    • Banking
    • Investments
    • Takeover
    • Food

    The entry of a strategic investor or the prospect of a takeover regularly leads to significant price surges and even massive revaluations. The momentum is enormous; the global market for mergers and acquisitions has reached new records. Especially during periods of technological upheaval, geopolitical realignment, and increasing competitive pressure, companies are increasingly turning to acquisitions to secure growth, resources, or market share. In this context, there are exciting and lucrative developments for investors at BioNxt Solutions, Delivery Hero, and Commerzbank. The investment case for BioNxt Solutions is particularly compelling. The Canadian company aims to bring an alternative to weight-loss injections to market. If successful, this could create a billion-dollar business and attract acquirers. How should investors position themselves?

    Read